Health

Remiges Ventures Closes Second Fund With $95 Million; Launches RDiscovery Incubator

Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Japan, announced today the final closing of its second fund, Remiges BioPharma Fund II raising a total of$95 million, and the launch of RDiscovery, a new life sciences incubator to nurture and ad...

2021-04-09 00:34 2191

Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T

SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr.Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr...

2021-04-08 22:00 13677

Harvard Research Identifies Policy Recommendations to Support Food Donation Across Five Continents

Amid pandemic and rising rates of food insecurity, Harvard Law School Food Law and Policy Clinic and The Global FoodBanking Network address global food waste and hunger crisis. CAMBRIDGE, Mass., April 8, 2021 /PRNewswire/ -- In response to food waste, climate change, and a global hunger crisis t...

2021-04-08 22:00 2206

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile

* Marks vaccine's first approval in South America, following Mexico, Pakistan, China and Hungary * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination TI...

2021-04-08 21:17 7215

ImmVira Announces Preclinical and Clinical Data to Be Presented at the 2021 ASCO and AACR Annual Meeting

SHENZHEN, China, April 8, 2021 /PRNewswire/ -- ImmVira today announces that the company will be presenting its first innovative product, MVR-T3011, at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting onJune 4-8 2021. Results from the first Phase 1 study of MVR-T3011 as an intr...

2021-04-08 20:47 2416

Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market

Amino acids dominate the global industry and are expected to generate revenues of$11.5 billion by 2026, says Frost & Sullivan SANTA CLARA, Calif., April 8, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the rising demand forhigh-quality meat products across the globe, especia...

2021-04-08 19:03 1890

Hyundai Bioscience leads in the repurposing of Niclosamide

SEOUL, South Korea, April 8, 2021 /PRNewswire/ -- A research paper by a South Korean bio tech company that demonstrated the drug repurposing of Niclosamide, an anthelmintic known to have excellent therapeutic efficacy against novel coronavirus infection (COVID-19), was published in the world-reno...

2021-04-08 17:17 1931

Notice to attend the Annual shareholders' meeting in Mentice AB

STOCKHOLM, April 8, 2021 /PRNewswire/ -- The shareholders of Mentice AB, reg. no. 566556-4241, (the "Company"), are hereby given notice to attend the annual shareholders' meeting to be held on6 May 2021 by completing a form for postal voting. A shareholder that wishes to attend the annual shareho...

2021-04-08 17:03 1587

Lunit will participate in a Groundbreaking Prospective Study to Validate AI Performance

* A research team at the Karolinska Institutet in Sweden will assess the performance of AI startup Lunit's breast cancer AI software as an independent mammography reader in screening * The prospective study marks first of its kind, aiming to screen 55,000 women with mammography at Capio Sankt...

2021-04-08 16:15 2158

SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software

BANGKOK, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickly ...

2021-04-08 15:00 2457

SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software

KUALA LUMPUR, Malaysia, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solut...

2021-04-08 15:00 2678

SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software

ABU DHABI, UAE, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can q...

2021-04-08 15:00 5375

SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software

SINGAPORE, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...

2021-04-08 15:00 2127

SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software

HONG KONG, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...

2021-04-08 15:00 2744

EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt® In China

TEL-AVIV, Israel, April 8, 2021 /PRNewswire/ -- EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announces today that EndoArt® was granted the Innovative Device Status byChina's Center for Medical Device Evaluation, the ar...

2021-04-08 08:00 2550

Daifuku Launches Into Modernisation of New Zealand Post's Major Processing Facilities

AUCKLAND, New Zealand, April 7, 2021 /PRNewswire/ -- Daifuku, recognised as the No. 1 material handling provider worldwide*, has been selected by New Zealand Post (NZ Post) to deliver the single largest material handling investment program withinNew Zealand in recent history.

2021-04-07 11:45 7199

Miguel Sieler Joins Cedrus Group as Director of EU Operations to Enhance Cedrus' Presence in Europe

HONG KONG, April 7, 2021 /PRNewswire/ -- Cedrus Group ("Cedrus" or "Group") , a global financial services and investment group, is pleased to announce that Mr.Miguel Sieler, a sophisticated and highly-reputable veteran in the life sciences industry, has joined...

2021-04-07 09:00 7526

Inmagene R&D Team expands with two new senior members joining the Company

SAN DIEGO and SHANGHAI and HANGZHOU, China, April 7, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced that Dr.Anbo Xiang and Dr.Qian Xu joined the company. As CMO (China) and Senior VP, Operations, Dr. Xiang will be responsible for clinical development, operations, an...

2021-04-07 09:00 17424

WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA

WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the U.S. FDA (FDA). T...

2021-04-07 08:22 22524

EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery

SHANGHAI and SUZHOU, China, April 7, 2021 /PRNewswire/ -- EDDA Healthcare and Technology Holding Ltd. and its subsidiaries EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc ( Princeton, NJ, USA), (hereafter jointly referred to as EDDA Techno...

2021-04-07 07:00 39247
1 ... 632633634635636637638 ... 858